Jobs / United States / Novartis Pharmaceuticals Corporation

Lifecycle Management Manager

Novartis Pharmaceuticals Corporation · 🇺🇸 Makati City

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles5 certified filings for “Finance Manager” (Financial Quantitative Analysts) in NJ: $73k–$113k, median $113k. Most were filed at wage level II (60%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Novartis Pharmaceuticals Corporation

75 H-1B filings certified since Oct 2025

The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →

About the role

Job Description Summary Lifecycle Management Manager Location : Makati Manila #LI-Hybrid As Lifecycle Management Manager, you will maximize the value of mature and transitioning brands by strengthening Loss of Exclusivity (LoE) readiness, leading seamless portfolio transitions, and executing strategies that sustain performance, protect profitability, and simplify operations. Ready to make a meaningful impact? Apply now and help us unlock lasting value for our portfolio, our business, and the patients we serve.   Job Description Key Responsibilities • Develop brand-specific LoE readiness plans, tracking milestones, risks, market dynamics, and value-protection actions. • Design and execute late lifecycle strategies, including portfolio simplification, SKU and pack optimization, targeted commercial interventions, and resource reallocation. • Lead the end-to-end transition of brands into the Commercial Portfolio, ensuring clear governance, accountabilities, documentation, budgets, forecasts, insights, and business continuity. • Assess portfolio performance and recommend investment, externalization, licensing, divestment, or retirement pathways based on value, risk, and complexity. • Partner across functions and markets to resolve dependencies, align priorities, and translate governance decisions into action. • Use analytics and business cases to support portfolio reviews, resource-allocation decisions, and performance tracking. • Build a high-performing, inclusive culture through clear goals, coaching, talent development, and accountability. Requirements: • Minimum 8 years of experience in lifecycle management, commercial operations, portfolio management, brand management, or a related discipline within pharmaceuticals, healthcare, or another regulated industry. • Strong knowledge of LoE planning, mature-brand strategy, portfolio optimization, forecasting, supply planning, and ongoing brand maintenance. • Proven track record with digital marketing • Proven success leading complex brand transitions and cross-functional initiatives across teams, markets, or business units. • Strong commercial and analytical acumen, with the ability to turn market, financial, and performance data into clear recommendations and business cases. • Understanding of regulatory, quality, legal, and pharmacovigilance interfaces; experience in externalization, divestment, licensing, or asset retirement is an advantage. • Excellent communication and influencing skills, with the ability to create alignment in a complex matrix environment. • An enterprise mindset, sound judgment, adaptability, and a strong focus on simplification, execution, and value creation.   Skills Desired Asset Management, Commercial Excellence, Cross-Functional Collaboration, Digital Marketing, Influencing Skills, Operational Excellence, Product Lifecycle Management (PLM), Product Marketing, Stakeholder Engagement, Stakeholder Management

View the official posting →

Source: Employer career site (Workday) First seen: 2026-08-31 Last confirmed: 2026-10-02 How our data works → Report this job

Similar opportunities